About Immunoscience India Private Limited
Data last updated:
Immunoscience India Private Limited is a foreign private limited company based in Pune, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 01 July 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2009FTC134231. Its GSTIN is 27AACCI1121K1ZV (Maharashtra).
The company has an authorised share capital of ₹10.95 Cr and a paid-up capital of ₹10.46 Cr. It is led by directors Amrut Dnyandeo Kare and Sateesh Apte.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 824/D Chintamani Apts. Bhandarkar Road Deccan, Pune, Maharashtra, India – 411004.
As per the financials filed for FY 2022, the company reported a revenue of ₹41.62 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.43 Cr (net margin 10.7%) and EBITDA of ₹5.86 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 137% over three years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website immunoscience.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address824/D Chintamani Apts. Bhandarkar Road Deccan, Pune, Maharashtra, India – 411004
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Immunoscience India Private Limited
The main business activity of Immunoscience India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Immunoscience India Private Limited FY 2024 filings available
Immunoscience India Private Limited reported revenue of ₹41.62 Cr (up 345% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Immunoscience India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 137% over three years, including 345% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Immunoscience India Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.43 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Immunoscience India Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Immunoscience India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Immunoscience India Private Limited
Immunoscience India Private Limited is audited by A S CHORBELE AND COMPANY for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A S CHORBELE AND COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Immunoscience India Private Limited
Immunoscience India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrut Dnyandeo Kare Also directs: Alpheus Pharma Private Limited, Roboscience India Private Limited | Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Sateesh Apte Also directs: Alpheus Pharma Private Limited, Roboscience India Private Limited | Director | 01 Jul 2009 | 17 Years 3 Months | Current |
Ownership and Shareholding of Immunoscience India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Immunoscience India Private Limited
Immunoscience India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Immunoscience India Private Limited
Immunoscience India Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Govt.Of India---Roc | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Immunoscience India Private Limited
Employment history and EPFO contributions of people linked to Immunoscience India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Immunoscience India Private Limited
Immunoscience India Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Atul Ramchandra Tarade ceased to be Director on 28 Oct 2024.
Credit Ratings, Litigation & Regulatory Alerts for Immunoscience India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Immunoscience India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Immunoscience India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Immunoscience India Private Limited
Immunoscience India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI1121K1ZV | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Immunoscience India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunoscience India Private Limited
Immunoscience India is an active foreign private limited company based in Pune, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 01 July 2009 (17+ years old) and is registered under CIN U73100PN2009FTC134231.
Immunoscience India reported revenue of ₹41.62 Cr for FY 2022 (up 345% YoY).
Immunoscience India has 2 current directors:
- Amrut Dnyandeo Kare - Director
- Sateesh Apte - Director
Immunoscience India reported a net profit of ₹4.43 Cr (net margin 10.7%) and EBITDA of ₹5.86 Cr (EBITDA margin 14.1%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Immunoscience India is 137% over three years. In the latest year (FY 2022) revenue rose 345%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Immunoscience India is 27AACCI1121K1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Immunoscience India is U73100PN2009FTC134231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunoscience India has 2 court cases on record: 2 filed against it.
Immunoscience India was incorporated on 01 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Pune.
Atul Ramchandra Tarade ceased to be Director on 28 Oct 2024. Mohit Gupta ceased to be Company Secretary on 30 Nov 2022. Amrut Dnyandeo Kare was appointed as Director on 01 Jul 2009. Immunoscience India has 4 board changes on record in total.